A monoclonal antibody stands out against omicron subvariants: a call to action for a wider access to bebtelovimab - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue The Lancet Infectious Diseases Année : 2022

Dates et versions

hal-03780992 , version 1 (20-09-2022)

Identifiants

Citer

Maxime Hentzien, Brigitte Autran, Lionel Piroth, Yazdan Yazdanpanah, Alexandra Calmy. A monoclonal antibody stands out against omicron subvariants: a call to action for a wider access to bebtelovimab. The Lancet Infectious Diseases, 2022, 22 (9), pp.1278. ⟨10.1016/S1473-3099(22)00495-9⟩. ⟨hal-03780992⟩
35 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More